According to new findings in Australia, a daily vitamin might help prevent the commonest type of skin cancers in people who are at high risk of disease.
According to a study conducted at the University of Sydney, nicotinamide, which is a form of vitamin B3, is shown to have reduce melanoma skin disease when taken twice daily.
The new research is a path to reduce the health crisis and the cost of skin cancer, which is the most commonly found disease in fair-skinned people (Caucasians mostly), according to the American Society of Clinical Oncology. The American society released this study on Wednesday just before its end of month annual meeting.
“It’s a cheap vitamin … one could be generous about starting it early if that’s a preference,” added Dr Peter Paul Yu, who is ASCO president and director of cancer research at Palo Alto Medical Foundation.
Exposure to ultraviolet radiation from the sun seems to be the primary cause of non-melanoma disease, which destroys cellular DNA and restrains the ability of skin’s immune system to exterminate abnormal cells.
Diona Damian said “We were looking to counter both pathways,” who is a professor of dermatology at the University of Sydney and is the study’s main author. She claimed that the study examining 386 patients, proved that nicotinamide minimized the risk for both basal and squamous cell carcinomas. (Two most common types of non-melanoma skin cancers)
The precautionary outcome commenced about three months after the treatment began, but paused after the patient discontinued consuming the vitamin, pointing to a “need to continue taking tablets for them to be effective,” Damian added.
Dr Damian also added that nicotinamide, is easily available and “almost obscenely inexpensive,” is not the same for niacin, ( form of vitamin B) which can cause side effects like headaches or low blood pressure.
The researchers admonished that people who are at high risk of skin cancer, should still wear sun protection (sunscreen) and have regular screenings for skin cancer.
Melanoma is the most fatal form, whereas squamous and basal cell carcinomas are the most common skin cancers.
Dr Damian mentioned that only people having high risk of skin cancer should use nicotineamide.”This is not something we would recommend for the general population,” she claimed.